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Chapter 4. Assessment of identification transfer in data dependent LC-
MS/MS experiments 
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4.1 Abstract 
Success of shotgun proteomics experiments is determined by the ability to accurately 
quantify and identify peptides in complex biological samples using liquid chromatography 
coupled with mass spectrometry (LC-MS(/MS)) datasets. To increase the number of peptide 
features (isotopic clusters) that can be identified in a single proteomics experiment analysed 
by LC-MS(/MS), several analytical improvements have been made in the past1–4. However, 
due to high sample complexity of biological samples, conventional high-resolution LC-
MS(/MS) datasets contain only a small fraction of annotated peptides compared to number 
of peptide features detectable in single-stage (MS1) LC-MS map. The main reason for such 
low identification rate is the mass analyzer’s bias towards highly abundant isotopic clusters 
in data dependent (DDA) LC-MS/MS analysis, low fragmentation efficiency or presence of 
highly complex MS/MS spectra e.g. due to co-fragmentation of peptides that are not 
identified by search algorithms sucessfully5,6. This study aims to assess the identification 
transfer process that is solely based on matching the retention time and m/z coordinates of 
annotated peptides features with unidentified peptide features of a target (sample) LC-
MS(/MS) dataset. In our approach the identification transfer is performed after correction of 
monotonic shift and assessment of orthogonality between reference and sample LC-
MS(/MS) datasets using the approach described in Mitra et al7. The performance of the 
algorithm was assessed based on calculation of false discovery rate (FDR) and calculating 
the difference between predicted and measured retention time values using leave-one-out 
cross-validation. The identification transfer process was characterized with respect to 
MS/MS spectral quality using Xrea8 score and abundance of peptide feature intensity. Our 
results show, that the identification transfer increases the annotation rate by an average of 
34.37% at FDR rate of ~5.5% in a test dataset obtained from Kim et al9. Ultimately, we report 
three classes of peptide features based on Xrea and precursor feature intensity values 
originally not annotated by database search: (1) peptides identified using identification 
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transfer (0.86 median Xrea) and (2) peptide features that remain unannotated after 
identification transfer (0.72 median Xrea) and (3) peptide features not submitted for MS/MS 
fragmentation. 
 
Manuscript in preparation.  
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4.2 Introduction 
Biological samples such as, as body-fluids, cell lines and tissues are composed of a complex 
mixture of proteins with dynamic concentration range reaching 12 orders of magnitude10–12. 
The most widely used approach to characterize the protein constitution of a biological 
sample is using shotgun proteomics, where proteins are first cleaved into smaller parts 
(peptides) with a protease (usually trypsin). The resulting peptide mixture is analysed 
primarily by data dependent acquisition LC-MS/MS (DDA LC-MS(/MS) ) approach and the 
resulting data is used for characterization of the measured proteomes. This analysis 
technique allows detection of several tens to hundreds of thousands of peptides in a single 
proteomics experiment, which maps to several thousands of proteins9. 
DDA LC-MS/MS data is composed from non-fragmented survey scans, which contains the 
quantitative information on the measured peptides in the form of 2-dimensional Gaussian 
isotopic peaks with dimensions of retention time, mass to charge ratio (m/z) as separation 
coordinate and quantitative ion intensity as quantitative readout. Data composed exclusively 
from this survey scans represent single stage (MS1) part of an LC-MS/MS dataset. Primary 
amino acid sequence of a peptide is determined from fragment mass spectrum (MS/MS). 
Peptide fragmentation follows specific rules and the mass of fragment ions can be used to 
ascertain the primary amino acid sequence of a peptide, which is known as a peptide 
spectrum match (PSM). The most widely used PSM algorithm uses a database search 
approach, which scores a match between measured MS/MS spectrum and predicted mass 
list of fragment ions from protein amino acids sequence that is assumed to be present in the 
sample1,2,13–15. Multiple approaches implement combined use of multiple database search 
algorithms into pipelines that enable high-throughput analysis to improve overall success of 
peptide annotations1,15. Identification of post-translation modifications (PTMs) is performed 
either with variable or static parameters set during the database search or open modification 
search algorithms, which enables further interrogation of bottom-up proteomics datasets. 
Commonly, database and open modification search algorithms identify PTM related mass 
shift of MS/MS fragments induced at specific primary amino acid sequence location1,2,16–19. 
Extending the search space to include multiple PTMs in a single data analysis step, can lead 
to increase in the sequence search space which further leads to the increase of false 
identifications or lower the number of identified peptides with corrected FDR rate20. The best 
current approach to identify PTMs and multiple sequence variants is the cascade approach, 
where the first step is performed without PTMs search using canonical sequence of UniProt 
or Ensembl. This is followed by identifying high-quality non identified spectra, which are 
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submitted to additional stepwise search for class of sequence variants such as non-
synonymous single nucleotide variants (SNVs), small indels or allele variants and classes 
of PTMs21,22. Another class of PSM algorithm called de novo sequencing annotates spectra 
without relying on reference sequence database. This approach allows identification of 
protein variants which are not present in the protein sequence database used for the 
database search, but requires complete ion series for unambiguous sequence 
reconstruction1,14,23,24. However, even after using several approaches and advanced search 
strategies to increase the number of successful peptide assignments, a large fraction (30-
70%) of MS/MS spectra remains unassigned. Furthermore, FDR assessment of combined 
search results to produce a final list of identified peptides and proteins, still remains 
challenging5. 
High-resolution LC-MS/MS platforms provide sufficient scanning speed, resolution and 
sensitivity for efficient peptide and protein identification. Despite ppm or sub-ppm level of 
mass accuracy in the MS and MS/MS scans, the precursor ion isolation window in the linear 
iontrap, which ensures sufficient sensitivity, is still few Da wide5. Therefore, the DDA ion 
sampling mode is biased towards high abundant ions due to either threshold setting that 
prevents sampling of low abundant ions or an eventual insufficient capacity to fragment all 
ions that pass the precursor ion intensity threshold25. Furthermore, due to the wide precursor 
ion isolation window, co-selection of multiple precursor ions may occur6. Fragmentation of 
multiple precursor ions results in complex MS/MS spectrum, which often leads to the failure 
of PSM assignment. Low precursor ion abundance and poor fragmentation efficiency leads 
to poor MS/MS spectral quality resulting in low MS/MS) identification rate25. Even the most 
advanced PTM search algorithms cannot identify peptides with complex PTMs such as 
glycopeptides, lipid modified peptides and ubiquitinated peptides, which lead to non-
identified high-quality MS/MS spectra. Combination of missing fragments in ion series and 
peptide sequence missing from protein sequence database forms an additional class of non-
identified high-quality MS/MS spectra. Therefore, analysis of highly complex samples that 
exhibit wide dynamic concentration range of proteins, have overall low to moderate 
successful identification rate of MS/MS spectra5. 
Performance assessment of the state-of-the-art orbitrap instruments, shows that complex 
samples such as HeLa S3 cells include more than 100,000 peptide like features (isotope 
clusters) are present in single LC-MS/MS experiment but only about 16% can be fragmented 
with an Orbitrap Velos mass spectrometer and 10% of the initial peptide features obtains 
successful annotation5. The fragmentation and annotation rate has been increased with the 
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recent introduction of QExactive+ and HF instruments, but the average identification rate of 
peptide features remains below 30%26. To identify peptide features (isotopic clusters), 
algorithms use MS1 information to construct two-dimensional Gaussian models fitted over 
m/z and retention time domains5,16,17,27. This step is known as feature detection and is 
implemented in common MS1 quantitative pre-processing pipelines such as MaxQuant28, 
OpenMS29, TAPP30 and mzMine31. The two-dimensional model uses Gaussian/Laurentian 
elution profile along the retention time axis and a theoretical isotope pattern along the m/z 
axis16,17. By mapping PSMs to a MS1 peptide features, it is possible to infer the number of 
peptide features that are successfully annotated in a single LC-MS/MS chromatogram. The 
proportion of isotopic clusters that can be identified successfully are mostly high abundant 
species. DDA mode ensures that the most abundant analytes are fragmented, and these 
spectra result in general MS/MS spectrum with high fragment intensity and high spectral 
quality25. 
On part of unidentified peptide features can be annotated by matching to annotated peptide 
features present in other LC-MS/MS chromatogram(s) after correction for monotonic 
retention time shifts. In this study we present an annotation transfer workflow based on our 
approach presented in Mitra et al.7. Our approach includes assessment of error associated 
with annotation transfer process matching unannotated and annotated peptide features 
between LC-MS(/MS) chromatograms using retention time and m/z coordinates. 
Identification transfer error is assessed by calculating false discovery rate (FDR) as a 
function of m/z and retention time peptide feature matching tolerance and by determining 
the distribution of the difference between the predicted and measured retention time values 
of peptide features involved in the identification transfer procedure. In our study we assess 
the impact of MS/MS spectral quality with Xrea8 approach and the peptide feature abundance 
on the efficiency of annotation transfer using subsets of the Human Proteome Map9 LC-
MS/MS dataset. 
4.3 Materials and Method 
4.3.1 LC-MS/MS dataset 
Raw mass spectrometry files acquired as part of the draft map of the human proteome (Kim 
et al.9) were downloaded from ProteomeXchange (http://proteomecentral.proteomexchange.org) 
using the PXD000561 identifier. 12 high-resolution raw LC-MS/MS files acquired with an 
LTQ Orbitrap Velos instrument were selected for the current study. The LC-MS/MS files 
were obtained from 3 fractions (14, 15 and 16) of adult kidney and adult esophagus tissue 
analyzed by two analytical methods: offline gel electrophoresis fractionation (gel) and high 
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and low pH C18 two dimensional LC-MS/MS approach (bRP). Table 1 provides the 
description of the main characteristics of the 12 raw LC-MS(/MS) files used in this study. 
From these files, those fractions that were analyzed using the same analytical method and 











14 10605 8770 4171 2033 1557 47.56 
15 10490 8818 4105 2078 1563 46.55 
16 10759 9094 3952 2002 1437 43.46 
kidney/gel 
14 13304 7842 6006 3940 1371 76.59 
15 17325 7707 5891 3998 1384 76.44 
16 15423 7480 5205 3733 1249 69.59 
esophagus/bRP 
14 16995 7482 2741 1917 1233 36.63 
15 17909 7785 2668 1892 1249 34.27 
16 17280 7075 2452 1701 1167 34.66 
esophagus/gel 
14 18982 7683 5509 3717 979 71.70 
15 18152 7676 5609 3558 833 73.07 
16 14879 7932 5594 3090 854 70.52 
Table1. Main characteristics of LC-MS/MS data files used in this study, which include the number (#) of MS/MS 
spectra, peptide features (isotope clusters determined by PEAKS Q module), PSM, identified unique peptide 




4.3.2 LC-MS/MS pre-processing and peptide and protein identification 
Identification of peptide sequences in the raw mass spectrometric data was performed using 
the PEAKS 7.032 search engine. MS/MS spectra were searched against the human UniProt 
database (version July 2014). Fragment mass tolerance was set to 0.1 Da, the precursor 
mass tolerance was set to 20 ppm and the number of allowed missed-cleavage was set to 
3. The enzyme used during the search was set to trypsin. Deamidation (NQ), oxidation (M) 
and phosphorylation (STY) was used as variable modification while carbamidomethylation 
was set as a fixed modification. De novo sequencing and PTM search with de novo and 
Spider modules were performed simultaneously and results from each level were combined 
by PEAKS. PSM, peptide and protein identification results were filtered at ≤1% FDR for 
PSM, peptides and proteins levels using at least 1 unique peptide per protein group. The 
final list of identification was exported in csv and pep.xml file formats. De novo MS/MS 
assignments were filtered for ≥70% average local confidence (ALC) score. Table 1 contains 
identification results for each of the 12 LC-MS/MS files. 
MS1 peptide features (isotope clusters close to isotope distribution obtained with average 
peptide atomic composition and using natural isotopologue abundance of atoms) 
identification and quantification in each of the raw LC-MS/MS files was performed by PEAKS 
Q module. To identify the isotopologues of an isotope cluster, PEAKS Q used mass error 
(decharged) tolerance window of 20.0 ppm and a retention time tolerance window of 3.0 
minutes and deconvoluted overlapped isotopic clusters using an expectation-maximization 
algorithm. The exported PSM search results in pep.xml format, were mapped to MS1 
features based on survey scan identifier and retention time. All annotation operations were 
performed with an in house R script, which resulted in a peptide features list constituted from 
unannotated features and peptides features annotated with PSM or scan identifiers of 
unannotated MS/MS spectra for each LC-MS/MS files. Monotonic retention time shifts 
between fractions of the same “tissue/analytical method” set was corrected by matching the 
peptide features that has the same peptide sequence annotation using our previously 
developed time alignment algorithm7. This was followed by grouping MS1 peptide features 
within fractions of one “tissue/analytical method” set using mass and retention time 
tolerances identified using Figure S1 (m/z tolerance of ±0.01 Da and retention time 
tolerance of ±1 minute). The procedure provided a quantified consensus peptide feature list 
annotated with PSM and unidentified MS/MS information for each “tissue/analytical method” 
set. 
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The MS/MS spectral quality was assessed for each raw MS/MS spectrum using a quality 
score called Xrea8 calculated by an in-house developed java program. Xrea score is computed 
from fragment ion (MS/MS) intensities normalized using a rank based cumulative procedure 
explained in supporting information and demonstrated in Figure S1. Xrea score uses only 
the raw intensities of fragment ions allowing assessment of MS/MS spectral quality 
independent to the identification status of the MS/MS spectrum8,33. The calculated Xrea 
scores were combined with the consensus peptide feature list of a “tissue/analytical method” 
set. Finally, four consensus “tissue/analytical method” peptide feature lists were obtained, 
which included information on the precursor-ion m/z (Da), precursor ion retention time 
(minutes), Xrea score, scan identifier of MS/MS spectrum in the original mzXML file, uniprot 
protein accession number, peptide primary amino acid sequence, decharged monoisotopic 
mass (Da), retention time (minutes) and ion intensities of a peptide features (ion counts). 
Peak elution order inversion assessment (presence of orthogonal separation), the 
calculation of the robust largest difference between peaks changing elution order (Dmax) 
between “tissue/analytical method” sets and correction for monotonic shift, was performed 
using our previously published approach7. For correction of monotonic shift, the retention 
time of the peptide features in the sample chromatogram were adjusted, while the retention 
time of the reference chromatogram remained unchanged. The pairs of annotated peptide 
feature list of different “tissue/analytical method” sets of interest corresponded to the 
chromatographic pair acquired “between laboratories” in our previous work, while annotated 
peptide feature list of different fractions of the same “tissue/analytical method” set 
corresponded to the reference chromatographic pair acquired “within laboratory”. 
 
4.3.4 Identification transfer 
The aim of the identification transfer is to annotate unidentified peptide features quantified 
in MS1 data. The identification transfer method in our implementation is based on matching 
corresponding peptide features based on retention time and m/z coordinates with the same 
tolerance that were used to match peaks within fractions of “tissue/analytical method” set. 
After correction of monotonic shifts and assessing if two peptide feature lists do not present 
significant orthogonality using our previously published approach, a pair of peptide feature 
lists of different “tissue/analytical method” set were used for peptide annotation transfer. The 
PSMs of annotated peptide features from the reference list that has a corresponding 
unidentified peptide feature in the sample list were used for annotation transfer, while 
common peptide features between lists can be used to assess the identification transfer 
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error (FDR and retention time difference between predicted and measured peptide features 
involved in identification transfer). In case of multiple corresponding peptide feature 
candidates in the sample list, the peptide feature closest in m/z value was chosen. The 
schematic representation of the procedure is shown in Figure S2. 
False discovery rate (FDR) of the identification transfer was assessed using leave-one-out 
cross validation (LOOCV)34 procedure and using the common annotated peptide features. 
The LOOCV procedure (Figure S3) splits the annotated peptide features common between 
the reference and sample datasets in 5 equal parts and uses 4 parts as training set to build 
the identification transfer model and uses the remaining part as test set. The test set (data 
not used to build the retention time correction function) is used to assess the model 
performance. The procedure is repeated five times which allows inclusion of all common 
peptide features as a model independent test set. FDR and annotation transfer error 
calculation were performed only using common annotated peptide features in the test set. 
The division of the data was repeated 100 times and the final FDR is calculated as average 
of FDR of each iteration. 
FDR was calculated based on the number of right matching (RM where the transferred 
peptide identity of the reference list corresponded to the peptide identity of the sample list) 
and erroneous matching (EM where the transferred peptide identity of the reference list 
differed from the peptide identity of the sample list) for a complete data as follow: 
FDR = 1 − RMRM+ EM 
The performance of the identification transfer procedure was assessed using different m/z 
(0.005, 0.05, 0.10, 0.15 and 0.20 Da) and retention time (1.00, 3.25, 5.50, 7.75 and 10.00 
minutes) values. The identification transfer was applied to all 6 possible combinations 
between “tissue/analytical method” sets. Scripting and statistical calculation was performed 
using R statistical language (R version 3.2.3), while the java code was developed using 
Eclipse Kepler environment (java version 1.8.0_11). The calculation was performed in a PC 
equipped with 8 GB of RAM and Intel core i5 CPU. The code is available at Github under 
the link of https://github.com/vikrammitra/IDtransfer.git. 
4.4 Results 
4.4.1 Quality assessment of combined LC-MS/MS datasets 
We have used a subset of a proteomics datasets analyzed with an LTQ Orbitrap Velos mass 
spectrometer, which included 12 LC-MS/MS datasets from study of Kim et al.9 The selected 
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datasets provide data obtained from kidney and esophagus tissues using two analytical 
fractionation approaches. Peptide and protein identification was performed using PEAKS as 
described in the Material and Methods. Across all MS/MS runs 7945 MS/MS spectra were 
selected for DDA of which 3830 PSMs were identified at 1% FDR (at PSM level) yielding an 
identification success rate of 48.48% on average (Table 1). However, we detected more 
than 15000 isotopic clusters at MS1 level on average. The higher number of peptide features 
(isotopic clusters) relative to lower number of MS/MS spectra, suggests undersampling of 
the LC-MS/MS system. Undersampling occurs if the molecular complexity of samples 
exceeds the fragmentation capacity of the LC-MS/MS platform35. The LC-MS/MS data in 
this study reflects the low scanning speed of Orbitrap Velos mass spectrometer, which has 
been already reported by Michalski et al. in a study analyzing HeLa S3 cervix carcinoma cell 
line25. 
Fractions were combined for a given “tissue/analytical method” set and were used for the 
identification transfer using retention time and m/z values of the annotated peptide features. 
Inaccurate transfer of annotations may occur if two combined datasets do not share common 
peaks in sufficient number, if monotonic retention time shift is not corrected and if 
orthogonality between dataset is considerable. We have assessed the number of common 
peaks between datasets, the probability of elution order of common peaks (i.e. orthogonality 
of separation between combined datasets) and corrected for monotonic shift using 
procedure as described in Mitra et al7. Table 2 shows the main characteristics of this 
assessment and Figure 1 shows the scatter plots of peptide features sharing the same 
peptide sequence in the 6 possible pairs of “tissue/analytical method” datasets. The 
probability of peak elution order inversion was assessed using F-test. The F-test was 
performed on the orthogonal residual variance (calculated relative to the main monotonic 
retention time trend of common annotated peptide features) between a “tissue/analytical 
method” dataset compared to the orthogonal residual variance obtained for fractions within 
a “tissue/analytical method” dataset. The F-test revealed that peak elution order inversion 
was significant between datasets of kidney/bRP and esophagus/bRP, kidney/bRP and 
esophagus/gel and kidney/gel and esophagus/gel using significance threshold of 0.01. 
However, in each of these cases the extent of orthogonality was limited as shown by Dmax, 
the value represent the maximal retention time difference of peaks changing elution 































kidney/gel 406 15273 20081 31.48 1.47·10-1 0.80 0.88 
esophagus/bRP 1121 6837 9267 35.54 1.48·10-23 0.81 2.80 
esophagus/gel 240 15033 20133 33.93 4.95·10-5 1.58 1.62 
kidney/gel 
esophagus/bRP 290 6837 11765 72.08 2.42·10-1 1.06 2.82 
esophagus/gel 1151 15033 20266 34.81 3.10·10-25 0.77 1.20 
esophagus/bRP esophagus/gel 403 15033 18179 20.93 5.80·10-2 1.85 2.26 
Table 2. Parameters that allow assessment of orthogonality between all 6 possible pairs of “tissue/analytical 
method” datasets shown in Figure 1. “Tissue/analytical method” dataset in bold resulted in non-significant 








































































Figure 1. Scatter plots of combined annotated peptide feature lists which have the common annotation in the 
6 possible pairs of “tissue/analytical method” datasets after correction for monotonic retention time shift 
according to Mitra et al7. Intensive scatter of the commonly annotated peptide features indicates the presence 
of orthogonality. This impacts accuracy of identification transfer between consensus “tissue/analytical method” 
datasets. Datasets kidney/bRP and kidney/gel, kidney/gel and esophagus/bRP, and esophagus/bRP and 
esophagus/gel does not have significant orthogonality (Table 2). 
 
4.4.2 Performance assessment of the identification transfer approach 
This section has the aim to determine the error rate of identification transfer approach 
performed using the closeness of retention time and m/z of decharged and isotope 
deconvoluted peptide features between pair of “tissue/analytical method” combined 
datasets. This type of identification transfer is used in LC-MS(/MS) data pre-processing 
workflows to decrease data sparsity caused by missing values28,36 and accurate mass and 
time tag (AMT) approach, which aims to transfer annotations between different LC-MS(/MS) 
datasets. Since PSM, peptide and protein identification in database search is strictly 
controlled using FDR calculation (e.g. using decoy approach), therefore it is important to 
determine the error introduced by identification transfer as a function of the m/z and retention 
time tolerances and the effect of an eventual presence of orthogonality characterized by the 
Dmax value. For error calculation common peptide features which have the same peptide 
sequence annotation obtained with PEAKS search were used as ground truth. Error rate of 
identification transfer was characterized by calculation of FDR and calculating the median 
retention time difference between the predicted and measured retention time of common 
annotated peptide features in the sample chromatogram (median prediction error). Figure 
2 shows how these two metrics change with thresholds for m/z (0.005, 0.05, 0.10, 0.15 and 
0.20 Da) and retention time (1.00, 3.25, 5.50, 7.75 and 10.00 minutes) for pairs of 
“tissue/analytical method” where orthogonality is not significant according to the F-test 
(Table 2). 
LOOCV procedure assured that error metric is calculated on a test set independent from the 
training set used for retention time alignment and identification transfer model building. 
Based on 3-dimensional scatter plots of Figure 2, the m/z threshold of ±0.005 Da and 
retention time threshold of ±1 minute provided the lowest median FDR level of 5.5%. 
However, this high FDR value also shows that in datasets where orthogonality is not 
significant and monotonic shift was corrected, the FDR rate of the identification transfer is 
higher than the stringent threshold of 1% used during PEAKS identification. This means that 
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identification transfer even with accurate correction for monotonic shift and non-significant 
orthogonality introduces larger error than combined results of database search and de novo 
sequencing by PEAKS. 
The median prediction error of retention time was not sensitive to the m/z threshold in the 
studied range, but was dependent on retention time threshold (Figure 2b). The median 
prediction error of retention time was lower than 0.1 minute for retention time tolerance lower 
than 3.25 minutes at all studied m/z tolerance in all three “tissue/analytical method” pairs 
with non-significant orthogonality. This result confirms the absence of significant 
orthogonality and the accurate correction of monotonic shift in the three “tissue/analytical 
method” datasets which were selected as suitable dataset for identification transfer. 
 
 
Figure 2. 3-dimensional scatter plots showing false discovery rate (FDR) in percentage (a) and the median 
differences between the predicted and measured retention time of common annotated peptides features (b) in 
function of m/z and retention time tolerance used for peptide feature matching. The size of each dot reflects 
the standard deviation of the calculated metrics. The m/z tolerance was varied at 0.005, 0.05, 0.10, 0.15 and 
0.20 Da and the retention time tolerance was varied at 1.00, 3.25, 5.50, 7.75 and 10.00 minutes. Dot colors 
















































































































































































































































Based on the FDR levels shown in Figure 2, a m/z tolerance ± 0.005 Da and a retention 
time tolerance of ± 0.1 minutes was used for optimal identification transfer between the three 
“tissue/analytical method” datasets with no significant orthogonality (kidney/bRP and 
kidney/gel, kidney/gel and esophagus/bRP, esophagus/bRP and esophagus/gel). Using 
these parameters for the identification transfer method, we observed a median increase of 
34.37% annotations in these three datasets compared to identification obtained with 
PEAKS. 
Figure 3 shows an example of a successfully transferred peptide primary amino acid 
sequence from reference chromatogram to the sample chromatogram. The left panel of 
Figure 3ab shows an isotopic cluster of peptide DADVQNFVSFISK identified by PEAKS in 
the fraction 14 of kidney/gel dataset. This annotation was transferred to a peptide feature 
with similar 3-dimensional MS1 profile in fraction 14 of kidney/bRP dataset using the 
identification transfer procedure, while Figure 3c shows the high similarity of the annotated 








Figure 3. Example of successful identification transfer from a MS/MS spectrum identified as peptide with 
sequence of DADVQNFVSFISK (735.37 Da and 65.71 minutes) in fraction 14 of the kidney/gel dataset to a 
peptide feature (735.37 Da and 65.53 minutes) in fraction 14 of the kidney/bRP dataset. (a) MS1 LC-MS/MS 
map surrounding the annotated (left panel) and unannotated (right panel) peptide feature. (b) 3-dimensional 
representation of the MS1 of LC-MS/MS data shown in (a). (c) MS/MS spectrum of the transferred peptide 
sequence with precursor ion with intensity of 4.26·105 (peptide feature intensity of 2.27·106) and an Xrea value 
of 0.85 from the reference set (left panel) and MS/MS spectrum of the spectrum unannotated with PEAKS 
search in the sample set with Xrea value of 0.83 (right panel) and precursor ion with intensity of 2.64·105 (peptide 
feature intensity of 1.26·106). 
 
4.4.3 Assessment of peptide features annotated with identification transfer 
To assess how the intensity of peptide features influences the MS/MS sampling rate, 
histogram of log10 feature intensity of all peptides detectable at MS1 level, MS1 peptide 
features selected for MS/MS fragmentation and those successfully identified with PEAKS 
and annotated exclusively with identification transfer were plotted (Figure 4). The ion 
intensity distributions of the identified peptide features and those targeted for MS/MS 
analysis, belong to the highly abundant species. Due to the stochastic nature of DDA MS/MS 
sampling, and the bias of DDA towards high-abundant MS1 signals resulted in high 
abundant peptide features submitted to MS/MS fragmentation and successful identification. 
In the current study, MS1 peptide features had a median intensity of 1.43·105 (5.16 on log10 
scale), peptide features with at least one MS/MS scan had a median intensity of 4.81·105 
(5.68 on log10 scale), peptide features annotated by PEAKS (PSMs) had median intensity of 
6.08·105 (5.78 on log10 scale) and peptide features exclusively annotated using identification 
transfer method had median intensity of 5.64·105 (5.75 on log10 scale). As a result, high-
abundant isotopic clusters from proteins such as HBA, ALBU, HBD or HBB were detected 
with high sequence coverage. Interestingly, SDS–PAGE gel fractionation shows higher 
MS/MS identification rate compared to the fractions obtained with bRP. However, this 
difference between the methods is difficult to assess from the analysed dataset, since not 
all fractions were included in the analysis. 
To assess the relationship between MS/MS identification rate, undersampling and the 
quality of MS/MS spectrum, we plotted the distribution of Xrea values for each dataset 
(Figure S4). The plots in Figure S4 show that higher quality MS/MS spectra with higher Xrea 
values have higher probability to be identified by PEAKS. This is reflected in the median Xrea 
value of 0.86 (±0.02) for the identified MS/MS spectra, while the median Xrea value of 
unidentified MS/MS spectra was 0.72 (±0.04). Since the fragmentation speed of the Orbitrap 
Velos mass spectrometer limits the capacity for fragmenting less abundant precursor ions 
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in presence of high number of coeluting peptides, most MS1 peptide features and the 
corresponding precursor ions are intense and have high Xrea values, as shown in Figures 
S5. Low abundant peptide features provide low quality MS/MS spectra. The upper plot in 
Figure S1 shows an unannotated low quality MS/MS spectrum with an Xrea value of 0.14 
obtained from a low abundant precursor with 1.15·104 ion counts and low abundant peptide 
precursor intensity (1.30·104 ion counts). High-quality MS/MS spectrum with high Xrea value 
of 0.85 and precursor and peptide precursor ion intensity of 8.0·105 was successfully 





























































































































































































































































































































































































































































































































































Figure 4. Histograms of log10 intensity of the detected peptide features (peptide isotope clusters) in 12 LC-
MS/MS datasets obtained from two tissue samples and two analytical approaches. Red density distribution 
shows all peptide features detectable in MS1 LC-MS/MS data. The green distribution shows the peptide 
features targeted for MS/MS fragmentation. The orange distributions belong to peptide features that obtained 
successful peptide annotation after database search with PEAKS. The blue distributions belong to peptide 
features annotated exclusively by the identification transfer procedure. 
The relationship between Xrea value of a MS/MS spectrum, ion intensity of the peptide precursor ion 
and annotation status of MS/MS spectrum is shown in scatter plots of Figure S5 (supporting 
information). These scatter plots shows that large proportion of MS/MS spectra with medium to high 
abundant peptide precursor ion have high Xrea values and have higher likelihood of being annotated 
by PEAKS. Plots in Figure S5 show three precursor ion populations not annotated by PEAKS and 
(1) can be annotated by identification transfer (0.86 median Xrea, 1.34·105median precursor 
intensity), (2) which remain unannotated even after identification transfer (0.72 median Xrea, 8.64·104 
median precursor intensity) and (3) peptide features not submitted for MS/MS fragmentation. Certain 
high-quality MS/MS spectra with high Xrea values and medium to high precursor ion intensity remain 
unannotated even after identification transfer. The reasons that these MS/MS spectrum are not 
identified can be due to the presence of peptides with PTMs not included in modification list during 
database search or protein sequences (e.g. amino acid substitutions, sequence variants) not present 
in the FASTA sequence database. In addition, some MS/MS spectrum could remained unannotated 
due to incomplete y and b ion series that prevents unambiguous de novo identification. MS/MS 
spectrum with incomplete y and b ions are sampled from a low abundant precursor ion for a given 
MS1 feature, results in poor quality and uninformative MS/MS spectra with low Xrea value. 
4.5 Conclusion 
We have assessed the performance of identification transfer approach, which matches 
annotated and unannotated MS1 peptide features between LC-MS(/MS) datasets using m/z 
and retention time coordinates. Our approach first assesses if non-significant orthogonality 
is present between pairs of LC-MS(/MS) chromatograms (individual or combined), corrects 
for monotonic shift and performs annotation of unidentified peptide features of sample 
chromatogram using annotated peptide features from reference chromatogram. The peptide 
features which are common between the two datasets are used to assess the orthogonality, 
to correct for monotonic shifts and to assess the error of the identification transfer in terms 
of FDR and median prediction error of retention time. The median prediction error of 
retention time reflects the accuracy of the time alignment, which is an important property of 
the MS1 LC-MS(/MS) quantitative data pre-processing. Identification transfer between 
datasets, with non-significant orthogonality showed larger error rate compared to matching 
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features based on peptide sequence annotation by PEAKS using 1% FDR at PSM, peptide 
and protein levels37. Reporting identification transfer error also provides indication of MS1 
data pre-processing quality, where peaks are matched solely by retention and m/z 
coordinate of peptide features or individual isotopologues peaks. In our test dataset we have 
shown an average increase of 34.37% in the identification rate of unidentified peptide 
features at FDR ~5.5%. We should emphasize that to determine the overall gain due to 
identification transfer, all fractions of a “tissue/analytical method” dataset should be 
processed and the FDR should be determined using double cross-validation in order to 
assess the method performance independent from the m/z and retention time tolerance 
parameter optimisation38,39. In addition, combining fractions is commonly performed in AMT 
approach where large number of individual samples are measured with MS1 LC-MS part 
only or in DDA LC-MS/MS mode and comprehensive fractionation is performed in pooled 
sample set with aim to annotate MS1 peptide features in individual samples40. 
In this study the combination of fractions even with correction of monotonic shift add an 
additional variability to the reference annotation, therefore lower error can be expected in 
transferring annotation between individual LC-MS/MS chromatograms. The later scenario is 
typical during LC-MS/MS data pre-processing. However feature matching using m/z and 
retention time coordinates in MS1 data pre-processing leads to decrease in data sparsity 
(missing values in statistical analysis) compared to workflow which match only the identified 
peptides41. Ultimately, by creating a more complete quantitative data matrix enables more 
accurate downstream statistics and more accurate identification of differentially expressed 
peptides and proteins. 
We have demonstrated that the identification transfer can increase identification rates by 
annotating peptide features that are missed by standard peptide identification or are 
unavailable for DDA precursor selection. In the current study, we have used Xrea to measure 
MS/MS spectral quality, a score which is independent from the identification status of an 
MS/MS spectrum. We used this score to assess the relationship between MS/MS spectral 
quality, precursor ion intensity and identification status. We have found that peptide features 
successfully annotated by identification transfer have low to medium abundant precursor ion 
intensity and a median Xrea value of 0.86. Peptide features not submitted to MS/MS 
fragmentation was an additional class of successfully annotated peptide features by 
identification transfer. These peptide features without any MS/MS could not be incorporated 
in the identification error assessment procedure. Annotation transferred to peptides features, 
that have high-quality MS/MS spectra and high-abundant precursor ion are most probably 
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erroneous transfer, since those spectra contain enough information to be identified with 
regular search engines. Furthermore, PTMs not addressed by the search engine or peptide 
sequences not included in the protein sequence database could be a primary reason for 
missing identification across all datasets. 
We have illustrated that in DDA LC-MS(/MS) identification transfer can increase the 
annotation status of MS1 peptide features, but the accuracy of the procedure should be 
carefully assessed. Mass spectrometry profiling of proteins and also metabolites are 
increasing being acquired using data independent acquisition (DIA)42, where identification 
transfer plays less important role. In DIA workflow first large collection of samples are 
acquired in DDA mode preferably using multidimensional fractionation. From the collected 
DDA data spectral library is constructed and the fragment ion intensity in consensus MS/MS 
spectra are then used to detect and quantify peptides data acquired in DIA mode. In this 
procedure retention time coordinate, m/z value and co-eluting chromatographic profile of the 
most intense fragment ions is used to transfer annotation from DDA generated spectral 
library to DIA41,43–46, which is less sensitive to orthogonality and has higher accuracy for 
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